Survival Benefit of Implantable-Cardioverter Defibrillator Therapy in Ambulatory Patients With Left Ventricular Assist Device

Simsek, EVRİM; Nalbantgil, S; Demir, EMRE; Kemal, HS; Mutlu, I; Ozturk, PELİN; Engin, ÇAĞATAY; Yagdi, TAHİR; Ozbaran, M

doi:10.1016/j.transproceed.2019.06.010

Survival Benefit of Implantable-Cardioverter Defibrillator Therapy in Ambulatory Patients With Left Ventricular Assist Device

Simsek E. , Nalbantgil S., Demir E. , Kemal H., Mutlu I., Ozturk P. , ...More

TRANSPLANTATION PROCEEDINGS, vol.51, no.10, pp.3403-3408, 2019 (Journal Indexed in SCI)

Publication Type: Article / Article
Volume: 51 Issue: 10
Publication Date: 2019
Doi Number: 10.1016/j.transproceed.2019.06.010
Title of Journal : TRANSPLANTATION PROCEEDINGS
Page Numbers: pp.3403-3408

Abstract

Background. Analysis of the prognostic effect of concomitant use of left ventricular assist devices (LVADs) and implantable -cardioverter defibrillators (ICDs) is lacking. The aim of this study is to define the survival effects of ICD therapy in ambulatory patients with LVAD.